TY - JOUR
T1 - Plasma Vitamin C and Type 2 Diabetes
T2 - Genome-Wide Association Study and Mendelian Randomization Analysis in European Populations
AU - Zheng, Ju-Sheng
AU - Luan, Jian'an
AU - Sofianopoulou, Eleni
AU - Imamura, Fumiaki
AU - Stewart, Isobel D.
AU - Day, Felix R.
AU - Pietzner, Maik
AU - Wheeler, Eleanor
AU - Lotta, Luca A.
AU - Gundersen, Thomas E.
AU - Amiano, Pilar
AU - Ardanaz, Eva
AU - Chirlaque, Maria-Dolores
AU - Fagherazzi, Guy
AU - Franks, Paul W.
AU - Kaaks, Rudolf
AU - Laouali, Nasser
AU - Mancini, Francesca Romana
AU - Nilsson, Peter M.
AU - Onland-Moret, N. Charlotte
AU - Olsen, Anja
AU - Overvad, Kim
AU - Panico, Salvatore
AU - Palli, Domenico
AU - Ricceri, Fulvio
AU - Rolandsson, Olov
AU - Spijkerman, Annemieke M. W.
AU - Sanchez, Maria-Jose
AU - Schulze, Matthias B.
AU - Sala, Nuria
AU - Sieri, Sabina
AU - Tjonneland, Anne
AU - Tumino, Rosario
AU - van der Schouw, Yvonne T.
AU - Weiderpass, Elisabete
AU - Riboli, Elio
AU - Danesh, John
AU - Butterworth, Adam S.
AU - Sharp, Stephen J.
AU - Langenberg, Claudia
AU - Forouhi, Nita G.
AU - Wareham, Nicholas J.
PY - 2021/1
Y1 - 2021/1
N2 - OBJECTIVEHigher plasma vitamin C levels are associated with lower type 2 diabetes risk, but whether this association is causal is uncertain. To investigate this, we studied the association of genetically predicted plasma vitamin C with type 2 diabetes.RESEARCH DESIGN AND METHODSWe conducted genome-wide association studies of plasma vitamin C among 52,018 individuals of European ancestry to discover novel genetic variants. We performed Mendelian randomization analyses to estimate the association of genetically predicted differences in plasma vitamin C with type 2 diabetes in up to 80,983 case participants and 842,909 noncase participants. We compared this estimate with the observational association between plasma vitamin C and incident type 2 diabetes, including 8,133 case participants and 11,073 noncase participants.RESULTSWe identified 11 genomic regions associated with plasma vitamin C (P <5 x 10(-8)), with the strongest signal at SLC23A1, and 10 novel genetic loci including SLC23A3, CHPT1, BCAS3, SNRPF, RER1, MAF, GSTA5, RGS14, AKT1, and FADS1. Plasma vitamin C was inversely associated with type 2 diabetes (hazard ratio per SD 0.88; 95% CI 0.82, 0.94), but there was no association between genetically predicted plasma vitamin C (excluding FADS1 variant due to its apparent pleiotropic effect) and type 2 diabetes (1.03; 95% CI 0.96, 1.10).CONCLUSIONSThese findings indicate discordance between biochemically measured and genetically predicted plasma vitamin C levels in the association with type 2 diabetes among European populations. The null Mendelian randomization findings provide no strong evidence to suggest the use of vitamin C supplementation for type 2 diabetes prevention.
AB - OBJECTIVEHigher plasma vitamin C levels are associated with lower type 2 diabetes risk, but whether this association is causal is uncertain. To investigate this, we studied the association of genetically predicted plasma vitamin C with type 2 diabetes.RESEARCH DESIGN AND METHODSWe conducted genome-wide association studies of plasma vitamin C among 52,018 individuals of European ancestry to discover novel genetic variants. We performed Mendelian randomization analyses to estimate the association of genetically predicted differences in plasma vitamin C with type 2 diabetes in up to 80,983 case participants and 842,909 noncase participants. We compared this estimate with the observational association between plasma vitamin C and incident type 2 diabetes, including 8,133 case participants and 11,073 noncase participants.RESULTSWe identified 11 genomic regions associated with plasma vitamin C (P <5 x 10(-8)), with the strongest signal at SLC23A1, and 10 novel genetic loci including SLC23A3, CHPT1, BCAS3, SNRPF, RER1, MAF, GSTA5, RGS14, AKT1, and FADS1. Plasma vitamin C was inversely associated with type 2 diabetes (hazard ratio per SD 0.88; 95% CI 0.82, 0.94), but there was no association between genetically predicted plasma vitamin C (excluding FADS1 variant due to its apparent pleiotropic effect) and type 2 diabetes (1.03; 95% CI 0.96, 1.10).CONCLUSIONSThese findings indicate discordance between biochemically measured and genetically predicted plasma vitamin C levels in the association with type 2 diabetes among European populations. The null Mendelian randomization findings provide no strong evidence to suggest the use of vitamin C supplementation for type 2 diabetes prevention.
KW - GENETIC-VARIATION
KW - ASCORBIC-ACID
KW - OXIDATIVE STRESS
KW - VEGETABLE INTAKE
KW - EPIC-NORFOLK
KW - LIFE-STYLE
KW - METAANALYSIS
KW - FRUIT
KW - DESIGN
KW - LEVEL
U2 - 10.2337/dc20-1328
DO - 10.2337/dc20-1328
M3 - Journal article
C2 - 33203707
SN - 0149-5992
VL - 44
SP - 98
EP - 106
JO - Diabetes Care. Supplement
JF - Diabetes Care. Supplement
IS - 1
ER -